Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

NF1 (neurofibromin 1)

Identity

HGNC NF1
Location 17q11.2
Location_base_pair Starts at 26446121 and ends at 26728821 bp from pter (hg18-Mar_2006).

DNA/RNA

Description 60 exons (57 constitutive, 3 alternative); spans 280 kb; presence of 3 cryptic genes: OMGP, EVI2A, and EVI2B ('overlapping genes'), hidden (!) within NF1 intron 27b with an opposite transcription direction.
Transcription at least 4 alternate splicings; ~ 9.0 kb mRNA complete cds; coding sequence: CDS 198..8717

Protein

Description the protein has been called neurofibromin; 2818 and 2839 amino acids (type-1 and type-2 isoform)
Expression is tissue and development stage specific
Function GTPase activating protein (GAP) interacting with p21RAS -> tumour suppressor.
Homology other (GAP); IRA1 and 2, the yeast inhibitors of p21RAS

Mutations

Germinal large submicroscopic deletions in 5-10% of cases, translocations rare and point mutations in app. 85-90% of cases; widely dispersed, with no clustering, unusual splicing mutations yield difficulties in molecular genetic testing, truncating effect in large majority of cases.
Somatic second inactivating mutation occurs in the Schwann cell of benign neurofibromas; additional genetic alterations in this cell lead to malignant transformation; the spectrum of inactivating somatic mutation not fully elucidated, LOH owing to copy number loss and mitotic recombination, point mutations; another inactivating process may involve RNA editing (for the second allele), which gives rise to a truncated neurofibromin having lost it's GAP activity.

Implicated in

Entity neurofibromatosis type 1
Disease autosomal dominant cancer prone disease; neurofibromatosis type 1 (NF1: the same symbol is used for the disease neurofibromatosis type 1 and the gene neurofibromin 1) is an hamartoneoplastic syndrome.
  
Entity Watson syndrome
Disease autosomal dominant disease with cardiac malformations, and, as is found in von Recklinghausen neurofibromatosis, low normal intelligence, café-au-lait spots, and neurofibromas but to a lesser extend.
Oncogenesis in accordance with the two-hit model for neoplasia, as is found in retinoblastoma.
  

External links

Nomenclature
HGNCNF1   7765
Entrez_GeneNF1  4763  neurofibromin 1
Cards
AtlasNF1ID134
GeneCardsNF1
EnsemblNF1 [Search_View]   ENSG00000196712 [Gene_View]
GenatlasNF1
GeneLynxNF1
eGenomeNF1
euGene4763
Genomic and cartography
GoldenPathNF1  -  17q11.2   chr17:26446121-26728821 +  17q11.2   [Description]    (hg18-Mar_2006)
EnsemblNF1 - 17q11.2 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneNF1
Gene and transcription
GenbankAB209336 [ ENTREZ ]
GenbankAF055023 [ ENTREZ ]
GenbankAF086346 [ ENTREZ ]
GenbankAK024873 [ ENTREZ ]
GenbankAK026658 [ ENTREZ ]
RefSeqNM_000267 [ SRS ]    NM_000267 [ ENTREZ ]
RefSeqNM_001042492 [ SRS ]    NM_001042492 [ ENTREZ ]
RefSeqNM_001128147 [ SRS ]    NM_001128147 [ ENTREZ ]
RefSeqAC_000060 [ SRS ]    AC_000060 [ ENTREZ ]
RefSeqAC_000149 [ SRS ]    AC_000149 [ ENTREZ ]
RefSeqNC_000017 [ SRS ]    NC_000017 [ ENTREZ ]
RefSeqNT_010799 [ SRS ]    NT_010799 [ ENTREZ ]
RefSeqNW_001838430 [ SRS ]    NW_001838430 [ ENTREZ ]
RefSeqNW_926772 [ SRS ]    NW_926772 [ ENTREZ ]
AceViewNF1 AceView - NCBI
UnigeneHs.113577 [ SRS ]    Hs.113577 [ NCBI ]     HS113577 [ spliceNest ]
Fast-db7838 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP21359 [ SRS]    P21359 [ EXPASY ]     P21359 [ INTERPRO ]     P21359 [ UNIPROT ]
PrositePS50191 CRAL_TRIO [ SRS ]    PS50191 CRAL_TRIO [ Expasy ]
PrositePS00509 RAS_GTPASE_ACTIV_1 [ SRS ]    PS00509 RAS_GTPASE_ACTIV_1 [ Expasy ]
PrositePS50018 RAS_GTPASE_ACTIV_2 [ SRS ]    PS50018 RAS_GTPASE_ACTIV_2 [ Expasy ]
InterproIPR001251 CRAL_bd_TRIO_C [ SRS ]    IPR001251 CRAL_bd_TRIO_C [ EBI ]
InterproIPR001936 RasGAP [ SRS ]    IPR001936 RasGAP [ EBI ]
CluSTrP21359
PfamPF00616 RasGAP [ SRS ]    PF00616 RasGAP [ Sanger ]    pfam00616 [ NCBI-CDD ]
SmartSM00323 RasGAP [EMBL]
SmartSM00516 SEC14 [EMBL]
BlocksP21359
PDB1NF1 [ SRS ]    1NF1 [ PdbSum ],   1NF1 [ IMB ]   1NF1 [ RSDB ]
PDB2D4Q [ SRS ]    2D4Q [ PdbSum ],   2D4Q [ IMB ]   2D4Q [ RSDB ]
PDB2E2X [ SRS ]    2E2X [ PdbSum ],   2E2X [ IMB ]   2E2X [ RSDB ]
HPRD01203
Protein Interaction databases
DIPP21359
IntActP21359
Polymorphism : SNP, mutations, diseases
OMIM162200;162210;193520;601321;607785    [ map ]   
GENECLINICS162200;162210;193520;601321;607785
SNPNF1 [dbSNP-NCBI]  
SNPNM_000267 [SNP-NCI]  
SNPNM_001042492 [SNP-NCI]  
SNPNM_001128147 [SNP-NCI]  
SNPNF1 [GeneSNPs - Utah]  NF1] [HGBASE - SRS]
HAPMAPNF1 [HAPMAP]  
COSMICNF1 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDNF1
General knowledge
Family BrowserNF1 [UCSC Family Browser]
SOURCENM_000267
SOURCENM_001042492
SOURCENM_001128147
SMDHs.113577
SAGEHs.113577
GOosteoblast differentiation [Amigo]  osteoblast differentiation
GOmetanephros development [Amigo]  metanephros development
GOresponse to hypoxia [Amigo]  response to hypoxia
GOliver development [Amigo]  liver development
GOnegative regulation of endothelial cell proliferation [Amigo]  negative regulation of endothelial cell proliferation
GOregulation of cell-matrix adhesion [Amigo]  regulation of cell-matrix adhesion
GOmolecular_function [Amigo]  molecular_function
GOGTPase activator activity [Amigo]  GTPase activator activity
GORas GTPase activator activity [Amigo]  Ras GTPase activator activity
GOprotein binding [Amigo]  protein binding
GOcellular_component [Amigo]  cellular_component
GOintracellular [Amigo]  intracellular
GOnucleus [Amigo]  nucleus
GOcytoplasm [Amigo]  cytoplasm
GOsignal transduction [Amigo]  signal transduction
GORas protein signal transduction [Amigo]  Ras protein signal transduction
GOnegative regulation of neuroblast proliferation [Amigo]  negative regulation of neuroblast proliferation
GObrain development [Amigo]  brain development
GOperipheral nervous system development [Amigo]  peripheral nervous system development
GOheart development [Amigo]  heart development
GObiological_process [Amigo]  biological_process
GOvisual learning [Amigo]  visual learning
GOphosphoinositide 3-kinase cascade [Amigo]  phosphoinositide 3-kinase cascade
GOspinal cord development [Amigo]  spinal cord development
GOforebrain astrocyte development [Amigo]  forebrain astrocyte development
GOcerebral cortex development [Amigo]  cerebral cortex development
GOmyelination in the peripheral nervous system [Amigo]  myelination in the peripheral nervous system
GOactin cytoskeleton organization and biogenesis [Amigo]  actin cytoskeleton organization and biogenesis
GOcollagen fibril organization [Amigo]  collagen fibril organization
GOadrenal gland development [Amigo]  adrenal gland development
GOnegative regulation of cell migration [Amigo]  negative regulation of cell migration
GOaxon [Amigo]  axon
GOdendrite [Amigo]  dendrite
GOpositive regulation of Ras GTPase activity [Amigo]  positive regulation of Ras GTPase activity
GOwound healing [Amigo]  wound healing
GOnegative regulation of transcription factor import into nucleus [Amigo]  negative regulation of transcription factor import into nucleus
GOnegative regulation of MAP kinase activity [Amigo]  negative regulation of MAP kinase activity
GOnegative regulation of MAPKKK cascade [Amigo]  negative regulation of MAPKKK cascade
GOpigmentation [Amigo]  pigmentation
GOpositive regulation of neuron apoptosis [Amigo]  positive regulation of neuron apoptosis
GOregulation of blood vessel endothelial cell migration [Amigo]  regulation of blood vessel endothelial cell migration
GOregulation of bone resorption [Amigo]  regulation of bone resorption
GOregulation of glial cell differentiation [Amigo]  regulation of glial cell differentiation
GOpositive regulation of adenylate cyclase activity [Amigo]  positive regulation of adenylate cyclase activity
GOregulation of angiogenesis [Amigo]  regulation of angiogenesis
GOnegative regulation of cell cycle [Amigo]  negative regulation of cell cycle
GOsympathetic nervous system development [Amigo]  sympathetic nervous system development
GOcamera-type eye morphogenesis [Amigo]  camera-type eye morphogenesis
GOnegative regulation of oligodendrocyte differentiation [Amigo]  negative regulation of oligodendrocyte differentiation
GOsmooth muscle development [Amigo]  smooth muscle development
GOartery morphogenesis [Amigo]  artery morphogenesis
GOforebrain morphogenesis [Amigo]  forebrain morphogenesis
GOcognition [Amigo]  cognition
GOregulation of small GTPase mediated signal transduction [Amigo]  regulation of small GTPase mediated signal transduction
BIOCARTAChromatin Remodeling by hSWI/SNF ATP-dependent Complexes    [Genes]
KEGGMAPK signaling pathway
PubGeneNF1
TreeFamNF1
CTD4763 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeNF1 Related clones (RZPD - Berlin)
PubMed
PubMed181 Pubmed reference(s) in Entrez

Bibliography

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.
Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P
Cell. 1990 ; 62 (1) : 193-201.
PMID 2114220
 
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.
Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA
Cell. 1990 ; 62 (1) : 187-192.
PMID 1694727
 
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.
Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL
Science (New York, N.Y.). 1990 ; 249 (4965) : 181-186.
PMID 2134734
 
Watson syndrome: is it a subtype of type 1 neurofibromatosis?
Allanson JE, Upadhyaya M, Watson GH, Partington M, MacKenzie A, Lahey D, MacLeod H, Sarfarazi M, Broadhead W, Harper PS
Journal of medical genetics. 1991 ; 28 (11) : 752-756.
PMID 1770531
 
Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.
Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, Harris R, Thakker N
American journal of human genetics. 1993 ; 53 (1) : 90-95.
PMID 8317503
 
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
Legius E, Marchuk DA, Collins FS, Glover TW
Nature genetics. 1993 ; 3 (2) : 122-126.
PMID 8499945
 
Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F
The New England journal of medicine. 1994 ; 330 (9) : 597-601.
PMID 8302341
 
Genomic organization of the neurofibromatosis 1 gene (NF1).
Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R, Viskochil D
Genomics. 1995 ; 25 (1) : 9-18.
PMID 7774960
 
Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I.
Metheny LJ, Cappione AJ, Skuse GR
Journal of neuropathology and experimental neurology. 1995 ; 54 (6) : 753-760.
PMID 7595647
 
A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.
Cappione AJ, French BL, Skuse GR
American journal of human genetics. 1997 ; 60 (2) : 305-312.
PMID 9012403
 
Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD
Human mutation. 2000 ; 15 (6) : 541-555.
PMID 10862084
 
Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.
Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, Mautner VF
Human mutation. 2004 ; 23 (2) : 111-116.
PMID 14722914
 
Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, Legius E, Callens T, Beiglbˆck H, Maertens O, Messiaen L
Genes, chromosomes & cancer. 2006 ; 45 (3) : 265-276.
PMID 16283621
 
Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lˆ°zaro C
Human molecular genetics. 2000 ; 9 (20) : 3055-3064.
PMID 11115850
 
Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lˆ°zaro C
Nature genetics. 2001 ; 28 (3) : 294-296.
PMID 11431704
 
High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.
Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, Krammer U, Peyrl A, Jenne DE, Hansmann I, Mautner VF
American journal of human genetics. 2004 ; 75 (3) : 410-423.
PMID 15257518
 
NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B
American journal of human genetics. 2005 ; 77 (6) : 1092-1101.
PMID 16380919
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written09-1997Jean-Loup Huret
Updated02-2006Katharina Wimmer

Citation

This paper should be referenced as such :
Huret JL . NF1 (neurofibromin 1). Atlas Genet Cytogenet Oncol Haematol. September 1997 .
URL : http://AtlasGeneticsOncology.org/Genes/NF1ID134.html
Wimmer K . NF1 (neurofibromin 1). Atlas Genet Cytogenet Oncol Haematol. February 2006 .
URL : http://AtlasGeneticsOncology.org/Genes/NF1ID134.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Oct 11 12:54:23 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.